You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonalcoholic Steatohepatitis

Showing 1 - 25 of 905
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) Trial in Hialeah Gardens

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Metabolic Dysfunction-associated Steatohepatitis (MASH)
  • Hialeah Gardens, Florida
    Site #430
Nov 1, 2023

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Recruiting
  • Nonalcoholic Steatohepatitis
  • Taipei, Taiwan
  • +1 more
Feb 8, 2023

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • +4 more
  • (no location specified)
May 17, 2023

Nonalcoholic Steatohepatitis With Advanced Fibrosis

Recruiting
  • Nonalcoholic Steatohepatitis
  • Standard of care
  • Richmond, Virginia
    Virginia Commonwealth University
Jan 31, 2023

Nonalcoholic Steatohepatitis Trial (Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule)

Not yet recruiting
  • Nonalcoholic Steatohepatitis
  • Rosuvastatin 20 Mg Oral Tablet
  • Coenzyme Q10 100 MG Oral Capsule
  • (no location specified)
Feb 7, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Guangzhou (ZSP1601, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Guangzhou, China
    NanFang Hospital
Jan 10, 2023

Non-Alcoholic Steatohepatitis (NASH) Trial in Fort Myers, Sarasota (Pemvidutide, Placebo)

Recruiting
  • Non-Alcoholic Steatohepatitis (NASH)
  • Fort Myers, Florida
  • +1 more
Aug 10, 2023

Patients With Nonalcoholic Steatohepatitis Trial (Group 1 or Experimental group, Group 2 or Control group)

Not yet recruiting
  • Patients With Nonalcoholic Steatohepatitis
  • Group 1 or Experimental group
  • Group 2 or Control group
  • (no location specified)
Nov 14, 2022

Nonalcoholic Steatohepatitis

Recruiting
  • Nonalcoholic Fatty Liver Disease (NAFLD)
  • Nonalcoholic Steatohepatitis (NASH)
  • Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE)
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Nov 11, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Tulsa, Waco (HTD1801, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Miami Lakes, Florida
  • +2 more
Jan 13, 2023

Nonalcoholic Steatohepatitis Trial in Rochester (OA-235i (4 mg), OA-235i (8 mg), OA-235i Dose 3)

Recruiting
  • Nonalcoholic Steatohepatitis
  • OA-235i (4 mg)
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 30, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Gent (ORMD-0801 QD, ORMD-0801 BD)

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • ORMD-0801 QD
  • ORMD-0801 BD
  • Gent, Belgium
    Universitaire Ziekenhuis Gent
Sep 15, 2022

Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Obesity Trial in United States (HU6, Placebo)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Montclair, California
  • +5 more
Jul 31, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in United States (Miricorilant 150 mg, Miricorilant 100 mg)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Miricorilant 150 mg
  • +2 more
  • Chandler, Arizona
  • +9 more
Oct 27, 2022

NASH - Nonalcoholic Steatohepatitis Trial in Cairo (pentoxifylline (Trental SR®))

Active, not recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • pentoxifylline (Trental SR®)
  • Cairo, Egypt
    Internal medicine and hepatology outpatient clinic at Ain Shams
Mar 9, 2022

Nonalcoholic Steatohepatitis (NASH) Trial (CS0159 (Linafexor))

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • CS0159 (Linafexor)
  • (no location specified)
Nov 14, 2022

Diabetes, Type 2, NASH - Nonalcoholic Steatohepatitis Trial in Tustin, Jerusalem, Tel Aviv (ORMD-0801 (Insulin) capsule 8 mg BD,

Completed
  • Diabetes Mellitus, Type 2
  • NASH - Nonalcoholic Steatohepatitis
  • ORMD-0801 (Insulin) capsule 8 mg BD
  • Placebo
  • Tustin, California
  • +2 more
Sep 13, 2022

NAFLD, Nonalcoholic Fatty Liver, NASH - Nonalcoholic Steatohepatitis Trial (LUM-201)

Recruiting
  • NAFLD
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 26, 2022

NASH - Nonalcoholic Steatohepatitis Trial in San Francisco (Spironolactone 100mg, Placebo oral capsule)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Spironolactone 100mg
  • Placebo oral capsule
  • San Francisco, California
    University of California San Francisco
Sep 9, 2022

Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • ASC41 2 mg
  • +2 more
  • (no location specified)
Jan 30, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in United States (BOS-580, Placebo)

Active, not recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Birmingham, Alabama
  • +11 more
Dec 4, 2022

Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver

Not yet recruiting
  • Nonalcoholic Fatty Liver Disease
  • Endoscopic Sleeve Gastroplasty
  • Morgantown, West Virginia
    West Virginia University
Aug 16, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Kaohsiung, Taiwan
  • +4 more
Apr 24, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in United States (Miricorilant, Placebo)

Terminated
Has Results
  • Nonalcoholic Steatohepatitis (NASH)
  • Chandler, Arizona
  • +14 more
Aug 10, 2022

NASH - Nonalcoholic Steatohepatitis Trial in United States (Seladelpar, Placebos)

Terminated
Has Results
  • NASH - Nonalcoholic Steatohepatitis
  • Glendale, Arizona
  • +13 more
Aug 30, 2022